UnknownPhase 1NCT04213612

DCV in the Treatment of Recurrence and Refractory Childhood Solid Tumors

Studying Cerebrotendinous xanthomatosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Sun Yat-sen University
Principal Investigator
Yizhuo Zhang
Sun Yat-sen University CancerCenter
Intervention
pegylated liposomal doxorubicin, cyclophosphamide, vincristine,(drug)
Enrollment
21 target
Eligibility
1-18 years · All sexes
Timeline
2019 – 2020

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04213612 on ClinicalTrials.gov

Other trials for Cerebrotendinous xanthomatosis

Additional recruiting or active studies for the same condition.

See all trials for Cerebrotendinous xanthomatosis →

← Back to all trials